Pamela Tenaerts

742 total citations
18 papers, 363 citations indexed

About

Pamela Tenaerts is a scholar working on Public Health, Environmental and Occupational Health, Economics and Econometrics and Physiology. According to data from OpenAlex, Pamela Tenaerts has authored 18 papers receiving a total of 363 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Public Health, Environmental and Occupational Health, 10 papers in Economics and Econometrics and 4 papers in Physiology. Recurrent topics in Pamela Tenaerts's work include Ethics in Clinical Research (8 papers), Health Systems, Economic Evaluations, Quality of Life (8 papers) and Biomedical Ethics and Regulation (4 papers). Pamela Tenaerts is often cited by papers focused on Ethics in Clinical Research (8 papers), Health Systems, Economic Evaluations, Quality of Life (8 papers) and Biomedical Ethics and Regulation (4 papers). Pamela Tenaerts collaborates with scholars based in United States, United Kingdom and Netherlands. Pamela Tenaerts's co-authors include Robert M. Califf, Bonnie Spring, Erin Iturriaga, Mark J. Pletcher, Katharine Cooper‐Arnold, Kenneth D. Mandl, Don S. Dizon, Omer T. Inan, Steven R. Steinhubl and Harlan M. Krumholz and has published in prestigious journals such as Journal of the American College of Cardiology, Nature Reviews Drug Discovery and Clinical Infectious Diseases.

In The Last Decade

Pamela Tenaerts

17 papers receiving 343 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pamela Tenaerts United States 8 144 96 94 41 40 18 363
Annemarie Forrest United States 9 199 1.4× 83 0.9× 127 1.4× 53 1.3× 44 1.1× 16 335
Arun Bhatt United States 10 184 1.3× 118 1.2× 95 1.0× 72 1.8× 28 0.7× 29 393
Katharine Cooper‐Arnold United States 5 75 0.5× 45 0.5× 87 0.9× 22 0.5× 12 0.3× 6 336
Lasse Østengaard Denmark 9 90 0.6× 34 0.4× 106 1.1× 21 0.5× 30 0.8× 17 396
Mira G. P. Zuidgeest Netherlands 12 178 1.2× 214 2.2× 126 1.3× 160 3.9× 61 1.5× 39 545
Lynda Ayiku United Kingdom 9 71 0.5× 49 0.5× 130 1.4× 6 0.1× 23 0.6× 21 456
Diane M. Korngiebel United States 12 209 1.5× 70 0.7× 198 2.1× 52 1.3× 11 0.3× 24 586
Kushal T. Kadakia United States 11 44 0.3× 86 0.9× 94 1.0× 33 0.8× 9 0.2× 48 300
Seamus Kent United Kingdom 14 105 0.7× 142 1.5× 76 0.8× 47 1.1× 10 0.3× 34 555
Camilla Hansen Nejstgaard Denmark 9 81 0.6× 77 0.8× 61 0.6× 27 0.7× 83 2.1× 24 403

Countries citing papers authored by Pamela Tenaerts

Since Specialization
Citations

This map shows the geographic impact of Pamela Tenaerts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pamela Tenaerts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pamela Tenaerts more than expected).

Fields of papers citing papers by Pamela Tenaerts

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pamela Tenaerts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pamela Tenaerts. The network helps show where Pamela Tenaerts may publish in the future.

Co-authorship network of co-authors of Pamela Tenaerts

This figure shows the co-authorship network connecting the top 25 collaborators of Pamela Tenaerts. A scholar is included among the top collaborators of Pamela Tenaerts based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pamela Tenaerts. Pamela Tenaerts is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Corneli, Amy, et al.. (2024). Participant comprehension and acceptability of enhanced versus text-only electronic informed consent: an innovative qualitative pilot study. Pilot and Feasibility Studies. 10(1). 10–10. 1 indexed citations
2.
Buse, John B., et al.. (2023). A framework for assessing clinical trial site readiness. Journal of Clinical and Translational Science. 7(1). e151–e151. 6 indexed citations
3.
Mowlem, Florence D., Pamela Tenaerts, Chad Gwaltney, & Ingrid Oakley‐Girvan. (2022). Regulatory Acceptance of Patient-Reported Outcome (PRO) Data from Bring-Your-Own-Device (BYOD) Solutions to Support Medical Product Labeling Claims. Therapeutic Innovation & Regulatory Science. 56(4). 531–535. 6 indexed citations
4.
Dombeck, Carrie, et al.. (2022). Stakeholders’ views on the most and least helpful aspects of the ICH E6 GCP guideline and their aspirations for the revision of ICH E6(R2). Contemporary Clinical Trials Communications. 29. 100983–100983. 2 indexed citations
5.
DiMasi, Joseph A., et al.. (2022). Assessing the Financial Value of Decentralized Clinical Trials. Therapeutic Innovation & Regulatory Science. 57(2). 209–219. 22 indexed citations
6.
Corneli, Amy, et al.. (2021). Stakeholders’ recommendations for revising Good Clinical Practice. Contemporary Clinical Trials Communications. 22. 100776–100776. 3 indexed citations
7.
Inan, Omer T., Pamela Tenaerts, Sheila A. Prindiville, et al.. (2020). Digitizing clinical trials. npj Digital Medicine. 3(1). 101–101. 199 indexed citations
8.
Godfrey, Alan, Jennifer C. Goldsack, Pamela Tenaerts, et al.. (2020). BioMeT and Algorithm Challenges: A Proposed Digital Standardized Evaluation Framework. IEEE Journal of Translational Engineering in Health and Medicine. 8. 1–8. 12 indexed citations
9.
Fordyce, Christopher B., Matthew T. Roe, Christine Pierre, et al.. (2019). Trends in clinical trial investigator workforce and turnover: An analysis of the U.S. FDA 1572 BMIS database. Contemporary Clinical Trials Communications. 15. 100380–100380. 7 indexed citations
10.
Tenaerts, Pamela, et al.. (2018). A decade of the Clinical Trials Transformation Initiative: What have we accomplished? What have we learned?. Clinical Trials. 15(1_suppl). 5–12. 7 indexed citations
11.
Johnston, S. Claiborne, Peter G. Goldschmidt, Greg Koski, et al.. (2017). It's Time to Harmonize Clinical Trial Site Standards. NAM Perspectives. 7(10). 5 indexed citations
12.
Stergiopoulos, Stella, Sara B. Calvert, Carrie Brown, et al.. (2017). Cost Drivers of a Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia Phase 3 Clinical Trial. Clinical Infectious Diseases. 66(1). 72–80. 13 indexed citations
13.
Roach, Nancy, et al.. (2016). Enhancing clinical evidence by proactively building quality into clinical trials. Clinical Trials. 13(4). 439–444. 47 indexed citations
14.
Pokorney, Sean D., Richard Platt, Tiffany S. Woodworth, et al.. (2016). LOW USE OF ORAL ANTICOAGULATION IN PATIENTS WITH ATRIAL FIBRILLATION AND RISK FOR STROKE IN THE UNITED STATES. Journal of the American College of Cardiology. 67(13). 886–886. 1 indexed citations
15.
16.
Tenaerts, Pamela, et al.. (2016). How Public–Private Collaborations Are Driving Solutions to the Antibacterial Drug Development Crisis. Clinical Infectious Diseases. 63(suppl 2). S25–S26. 1 indexed citations
17.
Stergiopoulos, Stella, et al.. (2015). Cost Drivers of Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia Phase Three Clinical Trials. Open Forum Infectious Diseases. 2(suppl_1). 4 indexed citations
18.
Tenaerts, Pamela, et al.. (2014). The Clinical Trials Transformation Initiative: innovation through collaboration. Nature Reviews Drug Discovery. 13(11). 797–798. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Annemarie Forrest Breakdown of academic impact, for papers by Arun Bhatt Breakdown of academic impact, for papers by Katharine Cooper‐Arnold Breakdown of academic impact, for papers by Lasse Østengaard Breakdown of academic impact, for papers by Mira G. P. Zuidgeest Breakdown of academic impact, for papers by Lynda Ayiku Breakdown of academic impact, for papers by Diane M. Korngiebel Breakdown of academic impact, for papers by Kushal T. Kadakia Breakdown of academic impact, for papers by Seamus Kent Breakdown of academic impact, for papers by Camilla Hansen Nejstgaard
Rankless by CCL
2026